1. Alroy, J., Haskins, M., Birk, D.E. (1999), Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VI, Exp Eye Res. 68: 523.
2. Cantor, B., Disseler, J.A., Wilson, F.M., 1989, Glaucoma in the Maroteaux- Lamy syndrome, Am J Ophthalmol. 108: 426.
3. Crawley, A.C., Brooks, D.A., Muller, V.J., Petersen, B.A., Isaac, E.L., Bielicki, J., King, B.M., Boulter, C.D., Moore, A.J., Fazzalari, N.L., Anson, D.S., Byers, S., Hopwood, J.J., 1996, Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome, J Clin Invest. 97: 1864.
4. Crawley, A.C., Niedzielski, K.H., Isaac, E.L., Davey, R.C.A., Byers, S., Hopwood, J.J., 1997, Enzyme replacement therapy from birth in a feline model of mucopolysacc-haridosis type VI, J Clin Invest. 99: 651.
5. Fillat, C., Simonaro, C.M., Yeyati, P.L., Abkowitz, J.L., Haskins, M.E., Schuchman, E.H., 1996, Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy, J Clin Invest. 98: 497.